All Keywords
【저자키워드】 thrombomodulin, interleukin-6, C-reactive protein, lactate dehydrogenase, von Willebrand factor, activated protein C, tissue factor pathway inhibitor, Disseminated intravascular coagulation, Tissue-type plasminogen activator, Tissue Factor, Urokinase-Type Plasminogen Activator, CRPC-reactive protein, LDHlactate dehydrogenase, DICdisseminated intravascular coagulation, APCactivated protein C, FVIIcoagulation factor VII, coagulation factor VII, FIXcoagulation factor IX, coagulation factor IX, IL-6interleukin-6, PAI-1plasminogen activator inhibitor type 1, plasminogen activator inhibitor type 1, PAR-1proteinase-activated receptor 1, proteinase-activated receptor 1, TFtissue factor, TFPItissue factor pathway inhibitor, t-PAtissue-type plasminogen activator, TMthrombomodulin, u-PAurokinase-type plasminogen activator, uPARurokinase-type plasminogen activator receptor, urokinase-type plasminogen activator receptor, vWFvon Willebrand factor, 【제목키워드】 Mortality, risk factor, Protein, disease, Admission, worsening, hospitalized patient, with COVID-19,
【저자키워드】 thrombomodulin, interleukin-6, C-reactive protein, lactate dehydrogenase, von Willebrand factor, activated protein C, tissue factor pathway inhibitor, Disseminated intravascular coagulation, Tissue-type plasminogen activator, Tissue Factor, Urokinase-Type Plasminogen Activator, CRPC-reactive protein, LDHlactate dehydrogenase, DICdisseminated intravascular coagulation, APCactivated protein C, FVIIcoagulation factor VII, coagulation factor VII, FIXcoagulation factor IX, coagulation factor IX, IL-6interleukin-6, PAI-1plasminogen activator inhibitor type 1, plasminogen activator inhibitor type 1, PAR-1proteinase-activated receptor 1, proteinase-activated receptor 1, TFtissue factor, TFPItissue factor pathway inhibitor, t-PAtissue-type plasminogen activator, TMthrombomodulin, u-PAurokinase-type plasminogen activator, uPARurokinase-type plasminogen activator receptor, urokinase-type plasminogen activator receptor, vWFvon Willebrand factor, 【제목키워드】 Mortality, risk factor, Protein, disease, Admission, worsening, hospitalized patient, with COVID-19,